BioLargo Income from Continuous Operations 2010-2025 | BLGO
BioLargo income from continuous operations from 2010 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
BioLargo Annual Income from Continuous Operations
(Millions of US $) |
| 2024 |
$-4 |
| 2023 |
$-5 |
| 2022 |
$-5 |
| 2021 |
$-7 |
| 2020 |
$-10 |
| 2019 |
$-11 |
| 2018 |
$-11 |
| 2017 |
$-10 |
| 2016 |
$-8 |
| 2015 |
$-5 |
| 2014 |
$-4 |
| 2013 |
$-3 |
| 2012 |
$-5 |
| 2011 |
$-4 |
| 2010 |
$-6 |
| 2009 |
$-16 |
BioLargo Quarterly Income from Continuous Operations
(Millions of US $) |
| 2025-03-31 |
$-2 |
| 2024-12-31 |
$-2 |
| 2024-09-30 |
$-1 |
| 2024-06-30 |
$-1 |
| 2024-03-31 |
$-1 |
| 2023-12-31 |
$-1 |
| 2023-09-30 |
$-2 |
| 2023-06-30 |
$-2 |
| 2023-03-31 |
$0 |
| 2022-12-31 |
$-1 |
| 2022-09-30 |
$-1 |
| 2022-06-30 |
$-1 |
| 2022-03-31 |
$-2 |
| 2021-12-31 |
$-2 |
| 2021-09-30 |
$-1 |
| 2021-06-30 |
$-2 |
| 2021-03-31 |
$-2 |
| 2020-12-31 |
$-2 |
| 2020-09-30 |
$-2 |
| 2020-06-30 |
$-3 |
| 2020-03-31 |
$-3 |
| 2019-12-31 |
$-3 |
| 2019-09-30 |
$-4 |
| 2019-06-30 |
$-2 |
| 2019-03-31 |
$-3 |
| 2018-12-31 |
$-2 |
| 2018-09-30 |
$-2 |
| 2018-06-30 |
$-4 |
| 2018-03-31 |
$-2 |
| 2017-12-31 |
$-2 |
| 2017-09-30 |
$-2 |
| 2017-06-30 |
$-3 |
| 2017-03-31 |
$-2 |
| 2016-12-31 |
$-2 |
| 2016-09-30 |
$-2 |
| 2016-06-30 |
$-2 |
| 2016-03-31 |
$-2 |
| 2015-12-31 |
$-1 |
| 2015-09-30 |
$-2 |
| 2015-06-30 |
$-1 |
| 2015-03-31 |
$-1 |
| 2014-12-31 |
$-1 |
| 2014-09-30 |
$-1 |
| 2014-06-30 |
$-1 |
| 2014-03-31 |
$-1 |
| 2013-12-31 |
$-1 |
| 2013-09-30 |
$-1 |
| 2013-06-30 |
$-1 |
| 2013-03-31 |
$-1 |
| 2012-12-31 |
$-2 |
| 2012-09-30 |
$-1 |
| 2012-06-30 |
$-2 |
| 2012-03-31 |
$-1 |
| 2011-12-31 |
$-1 |
| 2011-09-30 |
$-1 |
| 2011-06-30 |
$-1 |
| 2011-03-31 |
$-1 |
| 2010-12-31 |
$-1 |
| 2010-09-30 |
$-1 |
| 2010-06-30 |
$-1 |
| 2010-03-31 |
$-2 |
| 2009-12-31 |
$-10 |
| 2009-09-30 |
$-2 |
| 2009-06-30 |
$-2 |
| 2009-03-31 |
$-2 |
| Sector |
Industry |
Market Cap |
Revenue |
| Construction |
Engineering - Research & Development Services |
$0.061B |
$0.018B |
|
BioLargo Inc. is a cleantech and life sciences innovator and engineering services solution provider. The company's core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs. BioLargo Inc. is based in WESTMINSTER, CA.
|
